Matinas BioPharma Holdings, Inc. (MTNB): Operating Income
-$6.96M
Year ended 2025-12-31
-$6.67M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.96M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$24.59M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$23.77M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$24.59M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$24.73M | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | -$24.21M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$18.92M | n/m | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | -$14.65M | n/m | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | -$16.50M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$8.26M | n/m | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | -$9.91M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$10.46M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$3.71M | n/a | 2015-03-31, From 2013-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | -$6.96M | n/m |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | -$3.35M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$10.24M | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$470.0K | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$24.02M | n/m |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | -$28.73M | n/m |
| OS Therapies Inc (OSTX) | 2025-12-31 | -$28.71M | n/m |
| Rocket One Inc. (RKTO) | 2025-12-31 | -$12.36M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.28M | n/m |
Compare MTNB, CPMD, ENSC, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗